Ariad Pharmaceuticals et al. v. Eli Lilly and Company, 598 F.3d 1336 (Fed. Cir. 2010) (en banc), is a United States court case regarding accusations of ...


Apr 26, 2019 ... The '209 patent is owned by Eli Lilly & Co. and relates to ... article by John F. Worzalla, et al., titled "Role of Folic Acid in Modulating the Toxicity ...


Under the claim headed "market share liability" each plaintiff uniformly alleged that ... All defendants moved for summary judgment on all claims based on market ...


Parties, docket activity and news coverage of federal case ERFINDERGEMEINSCHAFT UROPEP GbR v. Eli Lilly and Company et al, case number ...


Collins v. Eli Lilly & Co. - 116 Wis. 2d 166, 342 N.W.2d 37. ... Company; Merck, Sharp & Dohme; William A. Webster Company; and others, .... 11 (1977); Note, Market Share Liability: An Answer to the DES Causation Problem, 94 Harv. L. Rev.


Sep 28, 2018 ... Parties, docket activity and news coverage of federal case Teva Pharmaceuticals International GmbH et al v. Eli Lilly and Company, case ...


Securities registered pursuant to Section 12(g) of the Act: None ...... Eli Lilly and Company, et al) seeking to assert product liability claims on behalf of a ... the company in the U.S. District Court for the Southern District of Indiana (Welch, et al . v.


Jan 15, 2009 ... American pharmaceutical giant Eli Lilly and Company today agreed to plead guilty and pay $1.415 billion for ... of the federal False Claims Act. The federal share of the civil settlement amount is $438 million. .... Rudolf, et al., v.


Eli Lilly and Company Shareholders' Equity (Note 8) ...... a jury in the Western District of Louisiana found in favor of the plaintiffs in the case of Allen, et al. v.